In this phase @ , multicenter , randomized , open-label study , patients were randomized ( @:@ ) to @ of the @ groups : everolimus @ mg ( targeted C@ of @-@ ng/mL ) plus reduced-dose cyclosporine or mycophenolate mofetil @ g/d plus standard-dose cyclosporine .